---
$id: https://graph.org.ai/products/commodity/51111906
$type: Product
source: UNSPSC
code: "51111906"
title: "Pegaspargase"
class: "51111900"
classTitle: "Natural antineoplastic products"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Pegaspargase

**UNSPSC Code**: 51111906
**Class**: [Natural antineoplastic products](Natural antineoplastic products.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a protein synthesis inhibitor with the molecular formula C1377H2208N382O442S17, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7D96IR0PPM, more generally known as pegaspargase. European Medicines Agency schedules pegaspargase in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03666MIG. The term PEGASPARGASE is an International Non-Proprietary Name or INN. see WHO INN reference publication, Volume 5, no. 3 1991, list 31. PEGASPARGASE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule pegaspargase under HS 35079090 and SITC 51691. As of Q4 2014, PEGASPARGASE remains the US FDA Preferred Term for this commodity. Pegaspargase bears US NLM identifiers UMLS ID C0071568 and NCI Concept Code C1200. SMILES: NONE.

